Literature DB >> 14600282

The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells.

Sandrine Bouhet1, Edith Hourcade, Nicolas Loiseau, Asmaa Fikry, Stephanie Martinez, Marianna Roselli, Pierre Galtier, Elena Mengheri, Isabelle P Oswald.   

Abstract

Fumonisin B1 (FB1) is a mycotoxin produced by Fusarium verticillioides (formerly F. moniliforme), a fungus that commonly contaminates maize. FB1 causes toxicological effects in laboratory and domestic animals including pigs. Because the gastrointestinal tract represents the first barrier met by exogenous food compounds, the purpose of this study was to investigate the effects of FB1 on IPEC-1, a porcine intestinal epithelial cell line. We first verified that low concentrations of FB1 did not exert any cytotoxic effect on IPEC-1. Indeed, significant LDH release was only observed for FB1 concentrations greater than 50 and 700 microM on proliferating and nonproliferating cells, respectively. We then demonstrated that FB1 inhibits proliferation of IPEC-1. Fluorescence-activated cell sorting (FACS) analysis of the cell cycle indicated that FB1 blocks the proliferation of intestinal cells in the G0/G1 phase. Similar results were obtained with LLC-PK1, a renal porcine epithelial cell line, which is considered to be a good model for studying FB1 in vitro effects. We have also assessed the effects of FB1 on the integrity of the barrier formed by the intestinal epithelium. We demonstrated that FB1 decreases the transepithelial electrical resistance (TEER) of IPEC-1 in a time- and dose-dependent manner. This effect was only noticed after a long exposure (8-12 days of treatment). FB1 induced the TEER decrease independently of the cell differentiation stage, and this effect was partially reversible. Taken together, our data indicate that FB1 alters the proliferation and the barrier function of intestinal cells. These results may have implications for humans and animals consuming FB1-contaminated food or feed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600282     DOI: 10.1093/toxsci/kfh006

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  44 in total

Review 1.  Ceramide signaling in the gut.

Authors:  Ying Li; Rebekah J Nicholson; Scott A Summers
Journal:  Mol Cell Endocrinol       Date:  2022-01-05       Impact factor: 4.102

2.  Effects of aflatoxin B(1) and fumonisin B(1) on the viability and induction of apoptosis in rat primary hepatocytes.

Authors:  Deise H B Ribeiro; Fabiane L Ferreira; Valéria N da Silva; Simone Aquino; Benedito Corrêa
Journal:  Int J Mol Sci       Date:  2010-04-26       Impact factor: 5.923

3.  Intestinal barrier function is modulated by short-term exposure to fumonisin B₁ in Ussing chambers.

Authors:  Jean-Paul Lallès; Martin Lessard; Gaëlle Boudry
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

4.  Cytotoxicity induced by nivalenol, deoxynivalenol, and fumonisin B1 in the SF-9 insect cell line.

Authors:  Francesca Fornelli; Fiorenza Minervini; Giuseppina Mulè
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 May-Jun       Impact factor: 2.416

Review 5.  Food chain mycotoxin exposure, gut health, and impaired growth: a conceptual framework.

Authors:  Laura E Smith; Rebecca J Stoltzfus; Andrew Prendergast
Journal:  Adv Nutr       Date:  2012-07-01       Impact factor: 8.701

Review 6.  Modulation of intestinal functions following mycotoxin ingestion: meta-analysis of published experiments in animals.

Authors:  Bertrand Grenier; Todd J Applegate
Journal:  Toxins (Basel)       Date:  2013-02-21       Impact factor: 4.546

7.  The food contaminant fumonisin B(1) reduces the maturation of porcine CD11R1(+) intestinal antigen presenting cells and antigen-specific immune responses, leading to a prolonged intestinal ETEC infection.

Authors:  Bert Devriendt; Me'lanie Gallois; Frank Verdonck; Yann Wache; Diane Bimczok; Isabelle P Oswald; Bruno M Goddeeris; Eric Cox
Journal:  Vet Res       Date:  2009-04-24       Impact factor: 3.683

8.  Porcine intestinal epithelial barrier disruption by the Fusarium mycotoxins deoxynivalenol and T-2 toxin promotes transepithelial passage of doxycycline and paromomycin.

Authors:  Joline Goossens; Frank Pasmans; Elin Verbrugghe; Virginie Vandenbroucke; Siegrid De Baere; Evelyne Meyer; Freddy Haesebrouck; Patrick De Backer; Siska Croubels
Journal:  BMC Vet Res       Date:  2012-12-17       Impact factor: 2.741

9.  Effect of low dose of fumonisins on pig health: immune status, intestinal microbiota and sensitivity to Salmonella.

Authors:  Christine Burel; Mael Tanguy; Philippe Guerre; Eric Boilletot; Roland Cariolet; Marilyne Queguiner; Gilbert Postollec; Philippe Pinton; Gilles Salvat; Isabelle P Oswald; Philippe Fravalo
Journal:  Toxins (Basel)       Date:  2013-04-23       Impact factor: 4.546

10.  Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging hypothesis through possible modulation of Th17-mediated response.

Authors:  Patricia M Cano; Julie Seeboth; François Meurens; Juliette Cognie; Roberta Abrami; Isabelle P Oswald; Laurence Guzylack-Piriou
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.